These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 25599709

  • 1. Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.
    Petersenn S, Beckers A, Ferone D, van der Lely A, Bollerslev J, Boscaro M, Brue T, Bruzzi P, Casanueva FF, Chanson P, Colao A, Reincke M, Stalla G, Tsagarakis S.
    Eur J Endocrinol; 2015 Jun; 172(6):R227-39. PubMed ID: 25599709
    [Abstract] [Full Text] [Related]

  • 2. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
    Fomekong E, Maiter D, Grandin C, Raftopoulos C.
    Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
    [Abstract] [Full Text] [Related]

  • 3. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease.
    Ioachimescu AG.
    Endocrinol Metab Clin North Am; 2018 Jun; 47(2):335-347. PubMed ID: 29754635
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.
    Rollin G, Ferreira NP, Czepielewski MA.
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1355-61. PubMed ID: 18209874
    [Abstract] [Full Text] [Related]

  • 5. Outcomes and management of patients with Cushing's disease without pathological confirmation of tumor resection after transsphenoidal surgery.
    Pouratian N, Prevedello DM, Jagannathan J, Lopes MB, Vance ML, Laws ER.
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3383-8. PubMed ID: 17595252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surgical management of Cushing's disease.
    Dallapiazza RF, Oldfield EH, Jane JA.
    Pituitary; 2015 Apr; 18(2):211-6. PubMed ID: 25724315
    [Abstract] [Full Text] [Related]

  • 9. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.
    Patil CG, Lad SP, Harsh GR, Laws ER, Boakye M.
    Neurosurg Focus; 2007 Apr; 23(3):E7. PubMed ID: 17961019
    [Abstract] [Full Text] [Related]

  • 10. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
    Kelly DF.
    Neurosurg Focus; 2007 Apr; 23(3):E5. PubMed ID: 17961026
    [Abstract] [Full Text] [Related]

  • 11. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
    Prevedello DM, Pouratian N, Sherman J, Jane JA, Vance ML, Lopes MB, Laws ER.
    J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
    [Abstract] [Full Text] [Related]

  • 12. PREDICTORS OF BIOCHEMICAL REMISSION AND RECURRENCE AFTER SURGICAL AND RADIATION TREATMENTS OF CUSHING DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Abu Dabrh AM, Singh Ospina NM, Al Nofal A, Farah WH, Barrionuevo P, Sarigianni M, Mohabbat AB, Benkhadra K, Carranza Leon BG, Gionfriddo MR, Wang Z, Mohammed K, Ahmed AT, Elraiyah TA, Haydour Q, Alahdab F, Prokop LJ, Murad MH.
    Endocr Pract; 2016 Apr; 22(4):466-75. PubMed ID: 26789343
    [Abstract] [Full Text] [Related]

  • 13. Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.
    Johnston PC, Kennedy L, Hamrahian AH, Sandouk Z, Bena J, Hatipoglu B, Weil RJ.
    Pituitary; 2017 Aug; 20(4):430-440. PubMed ID: 28265841
    [Abstract] [Full Text] [Related]

  • 14. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
    Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER.
    Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
    [Abstract] [Full Text] [Related]

  • 15. Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: outcomes with Cushing's disease.
    Sarkar S, Rajaratnam S, Chacko G, Mani S, Hesargatta AS, Chacko AG.
    Acta Neurochir (Wien); 2016 Jan; 158(1):77-86; discussion 86. PubMed ID: 26577636
    [Abstract] [Full Text] [Related]

  • 16. Update on radiation therapy in patients with Cushing's disease.
    Tritos NA, Biller BM.
    Pituitary; 2015 Apr; 18(2):263-8. PubMed ID: 25359445
    [Abstract] [Full Text] [Related]

  • 17. Results and predictors of outcome of endoscopic endonasal surgery in Cushing's disease: 20-year experience of an Italian referral Pituitary Center.
    Guaraldi F, Zoli M, Asioli S, Corona G, Gori D, Friso F, Pasquini E, Bacci A, Sforza A, Mazzatenta D.
    J Endocrinol Invest; 2020 Oct; 43(10):1463-1471. PubMed ID: 32215861
    [Abstract] [Full Text] [Related]

  • 18. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
    Wagenmakers MA, Boogaarts HD, Roerink SH, Timmers HJ, Stikkelbroeck NM, Smit JW, van Lindert EJ, Netea-Maier RT, Grotenhuis JA, Hermus AR.
    Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
    [Abstract] [Full Text] [Related]

  • 19. Approach to the postoperative patient with Cushing's disease.
    Rutkowski MJ, Breshears JD, Kunwar S, Aghi MK, Blevins LS.
    Pituitary; 2015 Apr; 18(2):232-7. PubMed ID: 25702104
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic options after surgical failure in Cushing's disease: A critical review.
    Rubinstein G, Osswald A, Zopp S, Ritzel K, Theodoropoulou M, Beuschlein F, Reincke M.
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101270. PubMed ID: 31036383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.